Faro Health Inc. is a Health Care startup founded in 2019 and headquartered in the United States. With the slogan "Clinical Development for the Digital Age," Faro Health is pioneering a cloud native platform to revolutionize clinical trials. The company's platform empowers study teams to design complex clinical trials using small modular building blocks while leveraging data-driven insights to orchestrate and automate operationally complex trials. Faro Health brings balance, centricity, and flexibility to protocol development through automation and integration to downstream systems and vendors, ensuring they are always up to date and correctly configured. Clinical trials using Faro Health are operationally efficient, avoiding delays due to ambiguity and generating trustworthy data. On 08 February 2023, Faro Health secured a significant $20.00M Series A investment from prominent investors including Zetta Venture Partners, Polaris Partners, General Catalyst, Northpond Ventures, and Section 32. This impressive funding highlights the confidence of leading venture capital firms in the potential of Faro Health's innovative approach to modernizing clinical trials.
No recent news or press coverage available for Faro Health.